Body Mass Index and Melanoma Prognosis
Open Access
- 28 September 2021
- journal article
- review article
- Published by Mattioli1885 in Dermatology Practical & Conceptual
- Vol. 11 (4) , e2021106
Abstract
Citation: Cassano N, Caccavale S, Vena GA, Argenziano G. Body mass index and melanoma prognosis. Dermatol Pract Concept. 2021;11(4): e2021106. DOI: https://doi.org/10.5826/dpc.1104a106 Accepted: March 5, 2021; Published: September 2021 Copyright: ©2021 Cassano et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License BY-NC-4.0, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: The authors have no conflicts of interest to disclose. Authorship: All authors have contributed significantly to this publication. Corresponding author: Stefano Caccavale, MD, Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Via Sergio Pansini, 5, 80131 Naples, Italy; phone: +39 3336365526; fax: +39 0815468759; Email: stefano85med@gmail.com Introduction: Obesity has been suggested as a risk factor in the progression of malignancies, including melanoma. Most studies defined obesity using body mass index (BMI), although the index is considered an imperfect measure of body composition. Objective: The aim of this article is to examine whether BMI can impact the prognosis of cutaneous melanoma, regardless of anti-tumor therapy. The relationship between BMI and specific prognostic factors in melanoma patients has been reviewed. Methods: Literature search was conducted on PubMed using the terms “melanoma” and “body mass index” or “obesity”. We selected articles, published up to 30 November 2020, examining the prognostic aspects of melanoma. Articles evaluating the risk and incidence of melanoma were excluded as well as studies regarding morbidity and complications following surgical procedures, or those performed in metastatic melanoma patients treated with anti-tumor therapies. Results: Mixed results have emerged from studies assessing the clinical outcomes in melanoma patients in relation to BMI. More consistent data seem to support the relationship between BMI and Breslow thickness. Conclusions: Studies that focus specifically on the link between obesity and melanoma prognosis are limited; further research is needed to deepen our knowledge on this link. Keywords : cutaneous melanoma, body mass index, Breslow thickness, obesity This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.Keywords
This publication has 49 references indexed in Scilit:
- Obesity and melanoma: Exploring molecular linksJournal of Cellular Biochemistry, 2013
- Adipocytes Promote B16BL6 Melanoma Cell Invasion and the Epithelial-to-Mesenchymal TransitionCancer Microenvironment, 2011
- Polymorphisms of Estrogen Receptors: Risk Factors for Invasive Melanoma – A Prospective StudyOncology, 2011
- Diet‐induced obesity increases melanoma progression: Involvement of Cav‐1 and FASNInternational Journal of Cancer, 2011
- Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case–control comparisons and a meta-analysis of published VDR dataEuropean Journal of Cancer, 2009
- Serum 25-Hydroxyvitamin D3 Levels Are Associated With Breslow Thickness at Presentation and Survival From MelanomaJournal of Clinical Oncology, 2009
- Environmental risk factors for relapse of melanomaEuropean Journal of Cancer, 2008
- Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studiesThe Lancet, 2008
- Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort studyBMJ, 2007
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003